Orgenesis (ORGS) 10-Q2024 Q3 Quarterly report

Filed: 13 Nov 24, 8:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abovementioned, adding, Africa, Article, ASEAN, authorized, Canada, caption, Claimant, Code, commonly, Comprehensive, confirmed, defer, deferral, distributing, earliest, employee, forum, Harley, Health, Healthcare, HSHG, inability, independent, Indian, join, jointly, judicial, Kingdom, lapsed, Latam, London, long, MENA, motion, nominate, Notification, official, open, opposition, OTCQX, payroll, percentage, petition, petitioned, petitioning, phase, Plc, preventative, procured, proper, reorganization, Street, Subcontinent, subscription, Subtopic, suspended, territory, thereunder, UAE, vendor

Removed: eligible, minimum, recent, satisfy, varied

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ORGS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

ORGENESIS INC.

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Vered Caplan, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(a)	The Quarterly Report on Form 10-Q of Orgenesis Inc. for the quarter ended September 30, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)	Information contained in the Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Orgenesis Inc.

By:

/s/ Vered Caplan
Vered Caplan
President & Chief Executive Officer
(Principal Executive Officer)
Date: November 13, 2024

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.